Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks
I just keep crunching the numbers. With current revenue ($4M) and estimated revenue ($8M by 5/15 earnings) with Canada, Mass, and Cali leases up and operating and even a p/e of 5 (which is ridiculous for a company growing almost 100% YOY and 100% in operating labs growth. We are on the brink once we can get it all together, which has been painfully slow. The repetitive late reports are definitely an issue but hope the right changes have been made. I know how lucky it is to get a good hire, who’s looking for a job at the exact moment you need someone who may or may not have other offerings. It’s really luck. I wish they would address the missed goals (no reduction of shares, missed openings on build out Cali Labs, reports and amount of labs). I think it’s best to communicate the fail and provide a new timeline. Things change but not all investors have the time or the resources to get all the information. If not a PR then a newsletter/email? I would say investor trust and confidence is definitely not there. I believe in the numbers and laws. That’s what keeps me here. I also own a business with a lot of turnover and I see how hard it is to get a good hire or even some people to show up for their interviews! With rapid expansion I can see how difficult it can be to staff and hire a location with trust worthy and dedicated staff with good work ethic and also skilled. Not making excuses just relaying my on going experience. In the end the numbers justify this company to an appropriate valuation with a p/e of 15x. Even though it took longer than expected the laws only just changed 16 days ago in 1/2 of our labs, and 2 Cali’s still left to open, expansion in Canada (didn’t see how soon that would be effective), and more equity in Berkeley. The pros and hard numbers outweigh the cons for me in the near future. Hope we can find a way to speed up our goals and be more timely or take the time to set new goals and communicate when goals are set back/missed. The latest update we had was 18 by 2018 end of year and ~$10M for estimated 2019. Would like to hear how many labs we expect to add this year as well.
Agree
There’s definitely a lot of irons in the fire with rapid expansion from coast to coast but they should not have PRd that (and with a specific timeline) if they didn’t intend to fulfill the promise. Also, when plans change they should PR those things. For example the Cali labs were suppose to be open by Q1, no into Q2 and no update. Long term I feel this is a winner but things are moving slower than we would all like. Most problems are learning curves of the overall market, changing of laws, and battling the black market (a trickle down effect). Can’t go wrong at these prices with a market cap of under $10M with revenue around $4M and going up.
Agree
4 weeks if it’s released on time..
Wasn’t the last one released after hours?
Lol and market cap still less than canopy ..
Mine was about that but I added 50% of my total at $0.35 so I’m probably about $1 average.
Of course with execution...
and with that $7.84M market cap being said and possibly $4M annual revenue last year this screams buy to me. A p/e of less than 2x? I believe our assets were about this much on our last filing. More ownership in labs, expansion of labs, new labs bringing in revenue, stricter testing. I can’t see this not trading at a p/e 15x and revenues significantly more for next year. I see a market cap of no less than $60M and even fully converted doubling share count I get a share price of $1.60 on lowest side. With a $10M year and $150M market cap fully converted shares and a p/e of 15x I get a share price of $4 by end of calendar year 2019.
Anyone want to comment on my math?
$7.84M* market cap
I’m getting 20,102,564 using the $9.84M market cap divided by the $0.39 share price. Would that be accurate? .. and how many preferred and not converted shares are there?
Agree for sure.
Great video thanks
On that*
Agree with you that.
So you are saying you can grow an experience. There is nothing better than real sun. I’m not arguing on quality alone. Indoor has a controlled environment. You can harvest 6 times a year (or as often as you want with diff rooms) vs once a year outside. Outside has higher chances of pest infestations and mold because of fluctuations in temperature and humidity. The flower from the 90s wouldn’t pass a mandating testing because it was sprayed with things like eagle 20. You don’t have to worry about over watering from excessive rain or contaminated rain water or outdoor Forrest fires smoke contaminating your crops. This is coming from a large picture. Everything has its pros and cons. Indoor pros outweigh outdoor pros.
Now that I can get on with. But even those will have other ingredients for different experience like craft beer now. Buttt a smoker is a smoker and a drinker is a drinker. I would much prefer a cannabis beverage at a bar over an alcoholic beverage. But I would much rather prefer a cannabis smoking lounge. Different strokes for different folks. I can say there is always tiered markets and cheap vodka or wine isn’t the same as high end and Kevin O’Leary will attest to that. That market concept is the same everywhere and most people prefer something in the middle for value sake. Cheapest isn’t the best or Natty Ice would be the number one selling beer. I know people who only drink craft beer vs domestic. If everyone wanted what was cheapest people wouldn’t wear Michael Khors, drive range rovers, or drink grey goose. All of these provide different experiences.
Now compare what you are saying to Tobacco. Vaping is healthy and cheaper but some people still buy Newport’s for $10 a pack or more. To say all Tobacco products give same experience from band to product. Chewing to dipping to smoking to vaping. If you made a drinkable tobacco product MOST people would still smoke real tobacco leaves.
Lol you obviously don’t smoke either. Is alcohol alcohol? There’s different terpenes for different flavors. That’s an experience. A sativa high and an indica high are completely different.
No way. You aren’t a smoker or grower if you feel that way. And when I used to term sugar leaves pertaining to sugar leaves on cannabis plant (which you obviously aren’t familiar with). I’d pay $250 for an ounce of quality with flavor an aroma and an experience, say grey goose or Coca Cola vs cheap well vodka or an rc cola. These new strains are phenotyped for specific experiences. $20 ounce outdoor cannabis isn’t going to have those experiences. I disagree with you 100%.
Extractions come from sugar leaves and trimmings and are really all profit (beside the labor and equipment used). Comparing cost of product for extracts and flower is apples and oranges IMO.
But as far as contaminated product goes it must be tested and pass each stage. Some solvents (butane and alcohol) will kill mold but it still will test as a dirty product because the mold is still there, it’s just dead.
Yea because indoor grows have perfect climate control and more harvests per year every 8 weeks. Included in that with strict testing regulations businesses don’t want to risk mold failure from outdoor grows. No doubt pricing will drop, especially as technology advances, I do not deny that but to compare the price of cost of goods and quality from 100 years ago is just stupid and an exaggeration. I
It costs too much now a days to grow quality for it to drop that low. Also how much were cheeseburgers when Cannabis was .01 a gram? Those points are super extreme.
Sorry $7.5B market cap. Whoops
My math with a p/e 15 gives a $7.5M market cap about $12 per share fair market value based on $500M revenue. I’m no expert.
I added 50% to my holdings under $0.40. I believe in the evio future and I understand the holdbacks that we are breaking through now. Laws took longer to implement than we all initially thought. I am patiently awaiting all the other catalyst you listed earlier. Although I am not so patient about the 2 Cali labs that I hoped would be generating revenue in Q1. But the future blueprint looking good IMO.
To clarify. By double in share structure I mean fully diluted.
With $5 million in revenue and a p/e of 15 that’s $75 million market cap. And a double in share structure I still get close to $2 in share price.
Nice bump today but we have a ways to go for those of us that have been in since sgby. Although it is right around the corner now! Hoping for news on our two Cali labs opening for business.
Good show called murder mountain on Netflix about black market cannabis in humbolt county.
Same. Market cap of just over $7 million. Everything is down. We are still awaiting a few things:
1. Two Cali labs to open.
2. Canadian cross listing.
3. Share reduction.
When is the next share holder meeting?
This market cap way undervalued. When something’s on sale you buy.
Current market cap is only $10million right now.
I am really more interested in these Cali labs we’ve been waiting on since October. I was hoping they would have been generating revenue for harvest season.
That was the first thing I was wondering when I read the PR.
I checked website still says coming soon. I’ve been waiting on updates for those labs since October.
I just added a bunch here and also a Canadian company today.
I would think and hope it’s related to opening of two Cali labs.